Orthopedic device developer Trilliant Surgical has raised $5 million in a new round of equity financing, according to a recently posted SEC filing.
Money in the round came from a single anonymous investor, with the date of the first sale noted on February 27, according to the filing.
The Houston, Texas-based company, founded in 2007, is developing devices for small bone orthopedic corrections including bone and joint elective and trauma procedures for the foot and ankle.
Trilliant is currently offering ten products for the forefoot, mid foot, rear foot and ankle, according to its website.
The company has not yet stated how it plans to spend funds in the round.
DeviceTalks West is just a few days away. Join more than 300 of your peers for a day of world-class education, networking, and a technology exhibition featuring the leading companies in the industry.
Don’t miss out on this premier opportunity to come together and share perspectives with the best of the best in the industry.
Use code LASTCHANCE to save an additional 20%.